CHARACTERISTICS OF RE-BIOPSIED NSCLC PATIENTS WITH ACQUIRED RESISTANCE TO EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS

被引：0

作者：

Arai, Daisuke ^{[1
]}

Soejima, Kenzo ^{[1
]}

Yasuda, Hiroyuki ^{[1
]}

Tani, Tetsuo ^{[1
]}

Kuroda, Aoi ^{[1
]}

Ishioka, Kota ^{[1
]}

Ohgino, Keiko ^{[1
]}

Sato, Takashi ^{[1
]}

Terai, Hideki ^{[1
]}

Ikemura, Shinnosuke ^{[1
]}

Hamamoto, Junko ^{[1
]}

Naoki, Katsuhiko ^{[1
]}

Hayashi, Yuichiro ^{[2
]}

Betsuyaku, Tomoko ^{[1
]}

机构：

[1] Keio Univ, Dept Med, Div Pulm Med, Sch Med, Tokyo 108, Japan

[2] Keio Univ, Dept Pathol, Sch Med, Tokyo 108, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷

关键词：

EGFR mutation; aquired resistance; re-biopsy;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.10-039

引用

页码：S581 / S582

页数：2

共 50 条

[1] Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC
Pallis, A. G.
Syrigos, K. N.
LUNG CANCER, 2013, 80 (02) : 120 - 130
[2] Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Wozniak, Antoinette J.
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (11) : S1084 - S1085
[3] Advances in targeting acquired resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors
Chen, Justin A.
Riess, Jonathan W.
JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 2859 - 2876
[4] Can acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors be overcome by different small-molecule tyrosine kinase inhibitors?
Bunn, Paul A., Jr.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) : 2504 - 2505
[5] Epidermal growth factor receptor tyrosine kinase inhibitors
M Ranson
British Journal of Cancer, 2004, 90 : 2250 - 2255
[6] Epidermal growth factor receptor tyrosine kinase inhibitors
Wakeling, AE
CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (04) : 382 - 387
[7] Epidermal growth factor receptor tyrosine kinase inhibitors
Ranson, M
BRITISH JOURNAL OF CANCER, 2004, 90 (12) : 2250 - 2255
[8] Histological transformation after acquired resistance to epidermal growth factor tyrosine kinase inhibitors
Shao, Yi
Zhong, Dian-Sheng
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (02) : 235 - 242
[9] Histological transformation after acquired resistance to epidermal growth factor tyrosine kinase inhibitors
Yi Shao
Dian-Sheng Zhong
International Journal of Clinical Oncology, 2018, 23 : 235 - 242
[10] New Strategies in Overcoming Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer
Oxnard, Geoffrey R.
Arcila, Maria E.
Chmielecki, Juliann
Ladanyi, Marc
Miller, Vincent A.
Pao, William
CLINICAL CANCER RESEARCH, 2011, 17 (17) : 5530 - 5537

← 1 2 3 4 5 →